Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
about
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies.Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioningTitle: Therapeutic strategies utilising SDF-1α in ischaemic cardiomyopathy.Exosomes and cardioprotection - A critical analysis.
P2860
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@en
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@nl
type
label
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@en
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@nl
prefLabel
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@en
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4.
@nl
P2093
P2860
P50
P1476
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4
@en
P2093
P2860
P304
P356
10.1007/S10557-015-6622-5
P577
2015-12-01T00:00:00Z